Alveus Therapeutics

Redefining Weight Management

Alveus Therapeutics was founded in 2024, is headquartered in Philadelphia, United States, lists 11–50 employees, and has $197.0M in recorded funding across 2 rounds.

Employees
11–50
Founded
2024
Business Model
B2B
Total Funding
$197.0M
Last Round
$37.0M Series AMar 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 10 investors for this company. The full record is or through the API.

About

Alveus Therapeutics is a clinical-stage biopharmaceutical company developing next-generation therapies for obesity and metabolic diseases. Its lead asset ALV-100 is currently in Phase 1b clinical trials, targeting sustainable weight loss with superior tolerability and reduced treatment burden. The company was founded in early 2024 and raised a $197 million Series A to advance its differentiated therapeutic pipeline.

Summary

Alveus Therapeutics is a Biotech company based in Philadelphia, United States, founded in 2024. It lists 11–50 employees. It has raised $197.0M in total across 2 rounds, most recently a $37.0M Series A round in Mar 2026. Investors include Andera Partners, Omega Funds and New Rhein.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMar 2026
$37.0M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alveus Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alveus-therapeutics"><img src="https://indexed.vc/api/badge/company/alveus-therapeutics" alt="Alveus Therapeutics on Indexed.vc" width="260" height="76" /></a>